Literature DB >> 10942196

Characterization of fibroblast cytoplasmic proteins that bind to the 3' UTR of human catalase mRNA.

B Ghosh1, E Barbosa, I Singh.   

Abstract

The excessive expression of catalase protein and its activity in cultured skin fibroblast from Zellweger Syndrome (ZS), a disorder of peroxisomal biogenesis, was found to be regulated at the translational level (J. Neurochem. 67: 2373-2378, 1996). Overall there is a considerable increase in the association of catalase mRNA with polysomes in ZS cell lines as compared to control indicating translational upregulation. To investigate the possibility that RNA-protein interactions are involved in the mediation of this increase in translation, the interaction between 3' untranslated region of human catalase mRNA and human fibroblast cytoplasmic proteins were investigated by RNA gel shift assay technique. Competition experiments demonstrated that all the 600 bases of 3' UTR (of human catalase gene) was required for efficient binding. Catalase RNA- protein interaction was sensitive to the altered redox state in these in vitro assays and this RNA-protein interaction could be enhanced by the addition of beta-mercaptoethanol in cytoplasm from control fibroblast but not in cytoplasm from ZS fibroblast. UV cross linked RNA-protein complexes on SDS polyacrylamide gel electrophoresis revealed the presence of at least four protein bands with approximate molecular masses of 38 kDa, 50 kDa, 66 kDa and 80 kDa. The potential role of these mRNA binding proteins in the regulation of catalase gene expression is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942196     DOI: 10.1023/a:1007024119640

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  21 in total

1.  An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA.

Authors:  P R Bohjanen; B Petryniak; C H June; C B Thompson; T Lindsten
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

2.  A 32-kilodalton protein binds to AU-rich domains in the 3' untranslated regions of rapidly degraded mRNAs.

Authors:  E Vakalopoulou; J Schaack; T Shenk
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

Review 3.  Prooxidant states and tumor promotion.

Authors:  P A Cerutti
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

4.  Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction.

Authors:  M W Hentze; T A Rouault; J B Harford; R D Klausner
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

Review 5.  Protein import into peroxisomes and biogenesis of the organelle.

Authors:  S Subramani
Journal:  Annu Rev Cell Biol       Date:  1993

Review 6.  Regulating the fate of mRNA: the control of cellular iron metabolism.

Authors:  R D Klausner; T A Rouault; J B Harford
Journal:  Cell       Date:  1993-01-15       Impact factor: 41.582

7.  Perinatal rat lung catalase gene expression: influence of corticosteroid and hyperoxia.

Authors:  L B Clerch; J Iqbal; D Massaro
Journal:  Am J Physiol       Date:  1991-06

Review 8.  Peroxisomal disorders. Neurodevelopmental and biochemical aspects.

Authors:  F R Brown; R Voigt; A K Singh; I Singh
Journal:  Am J Dis Child       Date:  1993-06

9.  Oxidation-reduction-sensitive binding of lung protein to rat catalase mRNA.

Authors:  L B Clerch; D Massaro
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

10.  Pex13p is an SH3 protein of the peroxisome membrane and a docking factor for the predominantly cytoplasmic PTs1 receptor.

Authors:  S J Gould; J E Kalish; J C Morrell; J Bjorkman; A J Urquhart; D I Crane
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

View more
  1 in total

1.  Evaluation of Potential Mechanisms Controlling the Catalase Expression in Breast Cancer Cells.

Authors:  Christophe Glorieux; Juan Marcelo Sandoval; Nicolas Dejeans; Sandrine Nonckreman; Khadija Bahloula; Hélène A Poirel; Pedro Buc Calderon
Journal:  Oxid Med Cell Longev       Date:  2018-01-28       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.